$ATRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANTARES PHARMA, INC.. Get notifications about new insider transactions in ANTARES PHARMA, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2013 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Grant | A | 0.00 | 27,778 | 0 | 138,213 | 110.4 K to 138.2 K (+25.15 %) |
| May 24 2013 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 0.00 | 27,778 | 0 | 345,976 | 318.2 K to 346 K (+8.73 %) |
| May 24 2013 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Grant | A | 0.00 | 55,556 | 0 | 182,385 | 126.8 K to 182.4 K (+43.80 %) |
| May 24 2013 | ATRS | ANTARES PHARMA, IN ... | HOBBS EAMONN P | Director | Grant | A | 0.00 | 27,778 | 0 | 122,860 | 95.1 K to 122.9 K (+29.21 %) |
| May 21 2013 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.00 | 17,000 | 68,000 | 126,829 | 143.8 K to 126.8 K (-11.82 %) |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 10,000 | 4,700 | 1,201,158 | |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.02 | 10,000 | 40,157 | 301,578 | 311.6 K to 301.6 K (-3.21 %) |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 10,000 | 4,700 | 311,578 | 301.6 K to 311.6 K (+3.32 %) |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Option Exercise | M | 0.50 | 10,000 | 5,000 | 1,605,793 | |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Sell | S | 4.04 | 10,000 | 40,350 | 523,547 | 533.5 K to 523.5 K (-1.87 %) |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Buy | M | 0.50 | 10,000 | 5,000 | 533,547 | 523.5 K to 533.5 K (+1.91 %) |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | DAVE KAUSHIK J | Executive Vice Pres ... | Option Exercise | M | 0.47 | 12,000 | 5,640 | 643,112 | |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | DAVE KAUSHIK J | Executive Vice Pres ... | Sell | S | 4.02 | 12,000 | 48,241 | 206,106 | 218.1 K to 206.1 K (-5.50 %) |
| May 08 2013 | ATRS | ANTARES PHARMA, IN ... | DAVE KAUSHIK J | Executive Vice Pres ... | Buy | M | 0.47 | 12,000 | 5,640 | 218,106 | 206.1 K to 218.1 K (+5.82 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 25,000 | 11,750 | 1,211,158 | |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.01 | 25,000 | 100,290 | 310,270 | 335.3 K to 310.3 K (-7.46 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 25,000 | 11,750 | 335,270 | 310.3 K to 335.3 K (+8.06 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 25,000 | 11,750 | 1,211,158 | |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.01 | 25,000 | 100,290 | 310,270 | 335.3 K to 310.3 K (-7.46 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 25,000 | 11,750 | 335,270 | 310.3 K to 335.3 K (+8.06 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Option Exercise | M | 0.50 | 25,000 | 12,500 | 1,615,793 | |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Sell | S | 4.01 | 25,000 | 100,300 | 537,393 | 562.4 K to 537.4 K (-4.45 %) |
| Jan 10 2013 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Buy | M | 0.50 | 25,000 | 12,500 | 562,393 | 537.4 K to 562.4 K (+4.65 %) |
| Dec 13 2012 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.50 | 5,000 | 7,500 | 0 | |
| Dec 13 2012 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.50 | 5,000 | 7,500 | 8,919,135 | 8.9 M to 8.9 M (+0.06 %) |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | M | 0.47 | 25,000 | 11,750 | 1,236,158 | |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Sell | S | 4.00 | 25,000 | 100,000 | 310,270 | 335.3 K to 310.3 K (-7.46 %) |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Buy | M | 0.47 | 25,000 | 11,750 | 335,270 | 310.3 K to 335.3 K (+8.06 %) |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Option Exercise | M | 0.50 | 25,000 | 12,500 | 1,640,793 | |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Sell | S | 4.00 | 25,000 | 100,008 | 537,393 | 562.4 K to 537.4 K (-4.45 %) |
| Dec 06 2012 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Buy | M | 0.50 | 25,000 | 12,500 | 562,393 | 537.4 K to 562.4 K (+4.65 %) |
| Nov 16 2012 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | P | 3.44 | 10,000 | 34,390 | 82,000 | 72 K to 82 K (+13.89 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Sell | S | 4.02 | 31,000 | 124,468 | 110,435 | 141.4 K to 110.4 K (-21.92 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.55 | 10,000 | 15,500 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.54 | 20,000 | 30,800 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.40 | 20,000 | 28,000 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.40 | 1,250 | 1,750 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 0.70 | 1,250 | 875 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 0.90 | 1,000 | 900 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 0.90 | 2,000 | 1,800 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 0.95 | 500 | 475 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 0.96 | 500 | 480 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.01 | 2,000 | 2,020 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 3,904 | 15,499 | 141,435 | 145.3 K to 141.4 K (-2.69 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.55 | 10,000 | 15,500 | 145,339 | 135.3 K to 145.3 K (+7.39 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 7,758 | 30,799 | 135,339 | 143.1 K to 135.3 K (-5.42 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.54 | 20,000 | 30,800 | 143,097 | 123.1 K to 143.1 K (+16.25 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 7,053 | 28,000 | 123,097 | 130.2 K to 123.1 K (-5.42 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.40 | 20,000 | 28,000 | 130,150 | 110.2 K to 130.2 K (+18.16 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 441 | 1,751 | 110,150 | 110.6 K to 110.2 K (-0.40 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.40 | 1,250 | 1,750 | 110,591 | 109.3 K to 110.6 K (+1.14 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 220 | 873 | 109,341 | 109.6 K to 109.3 K (-0.20 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 0.70 | 1,250 | 875 | 109,561 | 108.3 K to 109.6 K (+1.15 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 227 | 901 | 108,311 | 108.5 K to 108.3 K (-0.21 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 0.90 | 1,000 | 900 | 108,538 | 107.5 K to 108.5 K (+0.93 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 453 | 1,798 | 107,538 | 108 K to 107.5 K (-0.42 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 0.90 | 2,000 | 1,800 | 107,991 | 106 K to 108 K (+1.89 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 120 | 476 | 105,991 | 106.1 K to 106 K (-0.11 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 0.95 | 500 | 475 | 106,111 | 105.6 K to 106.1 K (+0.47 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 121 | 480 | 105,611 | 105.7 K to 105.6 K (-0.11 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 0.96 | 500 | 480 | 105,732 | 105.2 K to 105.7 K (+0.48 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 509 | 2,021 | 105,232 | 105.7 K to 105.2 K (-0.48 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.01 | 2,000 | 2,020 | 105,741 | 103.7 K to 105.7 K (+1.93 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.32 | 500 | 660 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.40 | 2,000 | 2,800 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.45 | 500 | 725 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.33 | 1,000 | 1,330 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.10 | 2,000 | 2,200 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.06 | 500 | 530 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.06 | 18,000 | 19,080 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.13 | 500 | 565 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.49 | 500 | 745 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.30 | 6,750 | 8,775 | 0 | |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 166 | 659 | 103,741 | 103.9 K to 103.7 K (-0.16 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.32 | 500 | 660 | 103,907 | 103.4 K to 103.9 K (+0.48 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 705 | 2,799 | 103,407 | 104.1 K to 103.4 K (-0.68 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.40 | 2,000 | 2,800 | 104,112 | 102.1 K to 104.1 K (+1.96 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 183 | 727 | 102,112 | 102.3 K to 102.1 K (-0.18 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.45 | 500 | 725 | 102,295 | 101.8 K to 102.3 K (+0.49 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 335 | 1,330 | 101,795 | 102.1 K to 101.8 K (-0.33 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.33 | 1,000 | 1,330 | 102,130 | 101.1 K to 102.1 K (+0.99 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 554 | 2,199 | 101,130 | 101.7 K to 101.1 K (-0.54 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.10 | 2,000 | 2,200 | 101,684 | 99.7 K to 101.7 K (+2.01 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 134 | 532 | 99,684 | 99.8 K to 99.7 K (-0.13 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.06 | 500 | 530 | 99,818 | 99.3 K to 99.8 K (+0.50 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 4,806 | 19,080 | 99,318 | 104.1 K to 99.3 K (-4.62 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.06 | 18,000 | 19,080 | 104,124 | 86.1 K to 104.1 K (+20.90 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 142 | 564 | 86,124 | 86.3 K to 86.1 K (-0.16 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.13 | 500 | 565 | 86,266 | 85.8 K to 86.3 K (+0.58 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 188 | 746 | 85,766 | 86 K to 85.8 K (-0.22 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.49 | 500 | 745 | 85,954 | 85.5 K to 86 K (+0.59 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Payment of Exercise | F | 3.97 | 2,210 | 8,774 | 85,454 | 87.7 K to 85.5 K (-2.52 %) |
| Aug 22 2012 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.30 | 6,750 | 8,775 | 87,664 | 80.9 K to 87.7 K (+8.34 %) |
| Jul 10 2012 | ATRS | ANTARES PHARMA, IN ... | DAVE KAUSHIK J | Executive Vice Pres ... | Option Exercise | A | 4.26 | 34,112 | 145,317 | 655,112 | |
| Jul 10 2012 | ATRS | ANTARES PHARMA, IN ... | DAVE KAUSHIK J | Executive Vice Pres ... | Grant | A | 0.00 | 21,127 | 0 | 213,721 | 192.6 K to 213.7 K (+10.97 %) |
| Jul 10 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | A | 4.26 | 21,658 | 92,263 | 1,261,158 | |
| Jul 10 2012 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 25,039 | 0 | 310,270 | 285.2 K to 310.3 K (+8.78 %) |
| Jul 10 2012 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Option Exercise | A | 4.26 | 110,293 | 469,848 | 1,665,793 | |
| Jul 10 2012 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | President and CEO | Grant | A | 0.00 | 54,773 | 0 | 537,393 | 482.6 K to 537.4 K (+11.35 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.60 | 40,000 | 64,000 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.10 | 26,009 | 28,610 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.53 | 174,849 | 92,670 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.85 | 105,616 | 89,774 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.65 | 61,870 | 102,086 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.55 | 10,000 | 15,500 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.54 | 20,000 | 30,800 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.40 | 20,000 | 28,000 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.40 | 1,250 | 1,750 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Sell | S | 2.85 | 87,500 | 249,463 | 318,198 | 405.7 K to 318.2 K (-21.57 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 22,067 | 63,994 | 405,698 | 427.8 K to 405.7 K (-5.16 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.60 | 40,000 | 64,000 | 427,765 | 387.8 K to 427.8 K (+10.32 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 9,865 | 28,609 | 387,765 | 397.6 K to 387.8 K (-2.48 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.10 | 26,009 | 28,610 | 397,630 | 371.6 K to 397.6 K (+7.00 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 31,955 | 92,670 | 371,621 | 403.6 K to 371.6 K (-7.92 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.53 | 174,849 | 92,670 | 403,576 | 228.7 K to 403.6 K (+76.44 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 30,956 | 89,772 | 228,727 | 259.7 K to 228.7 K (-11.92 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.85 | 105,616 | 89,774 | 259,683 | 154.1 K to 259.7 K (+68.55 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 35,202 | 102,086 | 154,067 | 189.3 K to 154.1 K (-18.60 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.65 | 61,870 | 102,086 | 189,269 | 127.4 K to 189.3 K (+48.56 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 5,345 | 15,501 | 127,399 | 132.7 K to 127.4 K (-4.03 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.55 | 10,000 | 15,500 | 132,744 | 122.7 K to 132.7 K (+8.15 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 10,621 | 30,801 | 122,744 | 133.4 K to 122.7 K (-7.96 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.54 | 20,000 | 30,800 | 133,365 | 113.4 K to 133.4 K (+17.64 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 9,655 | 28,000 | 113,365 | 123 K to 113.4 K (-7.85 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.40 | 20,000 | 28,000 | 123,020 | 103 K to 123 K (+19.41 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 603 | 1,749 | 103,020 | 103.6 K to 103 K (-0.58 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.40 | 1,250 | 1,750 | 103,623 | 102.4 K to 103.6 K (+1.22 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.70 | 1,250 | 875 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.90 | 2,000 | 1,800 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 0.95 | 500 | 475 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.01 | 2,000 | 2,020 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.32 | 500 | 660 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.40 | 2,000 | 2,800 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.10 | 2,000 | 2,200 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.06 | 16,500 | 17,490 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.13 | 500 | 565 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | M | 1.30 | 5,750 | 7,475 | 0 | |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 302 | 876 | 102,373 | 102.7 K to 102.4 K (-0.29 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.70 | 1,250 | 875 | 102,675 | 101.4 K to 102.7 K (+1.23 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 621 | 1,801 | 101,425 | 102 K to 101.4 K (-0.61 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.90 | 2,000 | 1,800 | 102,046 | 100 K to 102 K (+2.00 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 164 | 476 | 100,046 | 100.2 K to 100 K (-0.16 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 0.95 | 500 | 475 | 100,210 | 99.7 K to 100.2 K (+0.50 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 697 | 2,021 | 99,710 | 100.4 K to 99.7 K (-0.69 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.01 | 2,000 | 2,020 | 100,407 | 98.4 K to 100.4 K (+2.03 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 228 | 661 | 98,407 | 98.6 K to 98.4 K (-0.23 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.32 | 500 | 660 | 98,635 | 98.1 K to 98.6 K (+0.51 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 966 | 2,801 | 98,135 | 99.1 K to 98.1 K (-0.97 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Buy | M | 1.40 | 2,000 | 2,800 | 99,101 | 97.1 K to 99.1 K (+2.06 %) |
| May 31 2012 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Payment of Exercise | F | 2.90 | 759 | 2,201 | 97,101 | 97.9 K to 97.1 K (-0.78 %) |